Dave HodesJuly 14, 2022
The psychedelics industry today has focused mostly on finding, patenting, and taking to clinical trials some version of a psychedelic substance. But now that these substances are going deeper into clinical trials than ever before, the goals that researchers are working to achieve within a relatively straightforward biotech development cycle are to make psychedelics less […]